Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ubistesin Forte 4% / 1 in 100 000 injection, 1.7 mL cartridge |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ubistesin 4% / 1 in 200 000 injection, 1.7 mL cartridge |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Halaven 1 mg/2 mL injection, 2 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Omnitrope (somatropin 15 mg / 1.5 mL) injection: solution, 1.5 mL cartridge (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Narcan 400 microgram/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Orencia Ultrasafe Passive Needle Guard and Flange Extender 125 mg/mL injection, syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lignocaine Hydrochloride Min-I-Jet (UCB) 2% (100 mg/5 mL) injection, 5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (Medis) 8 mg/4 mL injection, 4 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (Medis) 4 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Serenace 20 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Serenace 10 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Simponi 100 mg/mL injection, syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Simponi Smartject (golimumab 100 mg / 1 mL) injection: solution, 1 mL syringe (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Valoid 50 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Dexmethsone 4 mg/mL injection, vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cisatracurium Concentrate (DBL) 5 mg/2.5 mL injection, 2.5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cisatracurium Concentrate (DBL) (cisatracurium 10 mg / 5 mL) injection, 5 mL vial (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
B-Dose IV injection, 2 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Paracetamol (Act) 1 g/100 mL injection, 100 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Reandron 1 g/4 mL injection: solution, 4 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cisatracurium (AFT) 5 mg/2.5 mL injection, 2.5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cisatracurium (AFT) 10 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cisatracurium (AFT) 150 mg/30 mL injection, 30 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Methotrexate (MYX) 50 mg/2 mL injection, 2 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Methotrexate (MYX) 1 g/10 mL injection, 10 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Pneumovax-23 25 microgram/0.5 mL injection: solution, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Calcium Gluconate (Phebra) 953 mg/10 mL injection, 10 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Calcium Gluconate (Phebra) 4.765 g/50 mL injection, 50 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Paramat 1 g/100 mL injection, 100 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy 125 microgram/0.5 mL injection: solution, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy (interferon beta-1a 125 microgram / 0.5 mL) injection: solution, 0.5 mL injection device (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Paracetamol (AFT) (paracetamol 1 g / 100 mL) injection, 100 mL vial (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ciprofloxacin (Alphapharm) 400 mg/200 mL injection, 200 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ciprofloxacin (Alphapharm) (ciprofloxacin 200 mg / 100 mL) injection, 100 mL bag (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Tropisetron (AFT) (tropisetron 2 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lignocaine (Pfizer) 1% (200 mg/20 mL) injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lignocaine (Pfizer) 2% (100 mg/5 mL) injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lignocaine (Pfizer) 2% (400 mg/20 mL) injection, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cisatracurium (Pfizer) 10 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (MYX) 4 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (MYX) 8 mg/4 mL injection, 4 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 623 mg (iodine 300 mg)/mL injection, 10 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 623 mg (iodine 300 mg)/mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 623 mg (iodine 300 mg)/mL injection, 50 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 623 mg (iodine 300 mg)/mL injection, 75 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 623 mg (iodine 300 mg)/mL injection, 100 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 (iopromide 623 mg / 1 mL) injection, 150 mL bottle (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 (iopromide 769 mg / 1 mL) injection, 20 mL vial (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 769 mg (iodine 370 mg)/mL injection, 30 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 769 mg (iodine 370 mg)/mL injection, 50 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 769 mg (iodine 370 mg)/mL injection, 75 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 769 mg (iodine 370 mg)/mL injection, 100 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 769 mg (iodine 370 mg)/mL injection, 200 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Gammanorm 1.65 g/10 mL injection, 10 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Gammanorm 3.3 g/20 mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (MYX) 50 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (MYX) 5 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (MYX) 5 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (MYX) 15 mg/3 mL injection, 3 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-240 499 mg (iodine 240 mg)/mL injection, 50 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy 125 microgram/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy (peginterferon beta-1a 125 microgram / 0.5 mL) injection, 0.5 mL pen device (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Mabthera SC 1.4 g/11.7 mL injection, 11.7 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Revatio 10 mg/12.5 mL injection, 12.5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Tranexamic Acid (Link) 500 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Arixtra 7.5 mg/0.6 mL injection, 0.6 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Arixtra 10 mg/0.8 mL injection, 0.8 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy 63 microgram/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy 94 microgram/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Alfentanil (GH) 5 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Alfentanil (GH) 1 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy 63 microgram/0.5 mL injection, 0.5 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Plegridy 94 microgram/0.5 mL injection, 0.5 mL pen device |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Fentanyl (GH) 500 microgram/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Fentanyl (GH) 100 microgram/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Herceptin SC 600 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Fentanyl (Aspen) 100 microgram/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Eylea 4 mg/0.1 mL injection, 0.1 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Eylea 4 mg/0.1 mL injection, 0.1 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
B-Dose Forte (Biological Therapies) injection, 2.5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lasix 20 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Morphine (Juno) 20 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Morphine (Juno) 100 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Morphine (Juno) 10 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Morphine (Juno) 50 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cosentyx 150 mg/mL injection, 1 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Cyklokapron 2 g/20 mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Copaxone 40 mg/mL injection, 1 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Vaxigrip 2015 injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Influvac 2015 (A/California/7/2009 (H1N1)-like virus 15 microgram + A/Switzerland/9715293/2013 (H3N2)-like virus 15 microgram + B/Phuket/3073/2013-like virus 15 microgram) injection, 0.5 mL syringe (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Influvac Junior 2015 injection, 0.25 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Vaxigrip Junior 2015 injection, 0.25 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 0.2% (Kabi) 40 mg/20 mL injection solution, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 0.5% (Kabi) 50 mg/10 mL injection solution, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 1% (Kabi) 100 mg/10 mL injection solution, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 1% (Kabi) 200 mg/20 mL injection solution, 20 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 0.2% (Kabi) 200 mg/100 mL injection solution, 100 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 400 mg / 200 mL) injection solution, 200 mL bag (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ropivacaine 0.75% (Kabi) 75 mg/10 mL injection solution, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|